Alexis Charalambides

Empire Capital Investments Public Ltd. is a investment holding company. The company's main activities include short and long-term investments in the securities of companies listed on the Cyprus Stock Exchange, the Athens Stock Exchange and on other international stock exchanges, as well as in mutual funds. The company is headquartered in Nicosia, Cyprus.

Empire Capital Investments Public Ltd. is a investment holding company. The company's main activities include short and long-term investments in the securities of companies listed on the Cyprus Stock Exchange, the Athens Stock Exchange and on other international stock exchanges, as well as in mutual funds. The company is headquartered in Nicosia, Cyprus.

Stario Investment Public Company Limited engages in the provision of investment services. It manages commercial enterprises through its subsidiaries in the restaurant and entertainment businesses. The company was founded on February 11, 2000 and is headquartered in Nicosia, Cyprus.

Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million.

Stario Investment Public Company Limited engages in the provision of investment services. It manages commercial enterprises through its subsidiaries in the restaurant and entertainment businesses. The company was founded on February 11, 2000 and is headquartered in Nicosia, Cyprus.

Stario Investment Public Company Limited engages in the provision of investment services. It manages commercial enterprises through its subsidiaries in the restaurant and entertainment businesses. The company was founded on February 11, 2000 and is headquartered in Nicosia, Cyprus.

Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million.

Stario Investment Public Company Limited engages in the provision of investment services. It manages commercial enterprises through its subsidiaries in the restaurant and entertainment businesses. The company was founded on February 11, 2000 and is headquartered in Nicosia, Cyprus.

Empire Capital Investments Public Ltd. is a investment holding company. The company's main activities include short and long-term investments in the securities of companies listed on the Cyprus Stock Exchange, the Athens Stock Exchange and on other international stock exchanges, as well as in mutual funds. The company is headquartered in Nicosia, Cyprus.

Empire Capital Investments Public Ltd. is a investment holding company. The company's main activities include short and long-term investments in the securities of companies listed on the Cyprus Stock Exchange, the Athens Stock Exchange and on other international stock exchanges, as well as in mutual funds. The company is headquartered in Nicosia, Cyprus.

Empire Capital Investments Public Ltd. is a investment holding company. The company's main activities include short and long-term investments in the securities of companies listed on the Cyprus Stock Exchange, the Athens Stock Exchange and on other international stock exchanges, as well as in mutual funds. The company is headquartered in Nicosia, Cyprus.

Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million.

Part of Medicover AB, NIPD Genetics Ltd. is a Cypriot biotechnology company. The company is based in Nicosia, Cyprus. The company was founded in 2010 by Philippos C. Patsalis. Philippos C. Patsalis has been the CEO since 2010. NIPD Genetics was acquired by Medicover AB on January 18, 2022 for $50.32 million.